- E34.322 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM E34.322 became effective on October 1, 2022.
- This is the American ICD-10-CM version of E34.322 – other international versions of ICD-10 E34.322 may differ.
ICD-10-CM E34.322 is grouped within Diagnostic Related Group(s):
- 643 Endocrine disorders with mcc
- 644 Endocrine disorders with cc
- 645 Endocrine disorders without cc/mcc
Applicable To
- Genetic syndrome with resistance to insulin-like growth factor-1
- Insulin-like growth factor-1 receptor (IGF-1R) defect
- Post-insulin-like growth factor-1 receptor signaling defect
Code History
- 2024 (effective 10/1/2022): New code
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to E34.322:
- genetic syndrome with resistance to insulin-like growth factor-1 > genetic causes E34.329
- insulin-like growth factor-1 receptor defect (IGF-1R) > genetic causes E34.329
- insulin-like growth factor-1 resistance (IGF-1) > genetic causes E34.329
- post-insulin-like growth factor-1 receptor signaling defect > genetic causes E34.329